Starnatx
Suzhou, CN · 1 known investors
Find your way into Starnatx
Sign up to see every warm intro you have to Starnatx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Starnatx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Starna Therapeutics develops RNA-based therapeutic drugs focused on hepatic and extrahepatic targeted delivery technology. The company has built a proprietary platform of cationic lipids and lipid nanoparticles (LNPs) to achieve organ-specific delivery and is advancing clinical-stage mRNA vaccine and mRNA therapeutic candidates.
Investors · 1
Source Code Capitallisted by Source Code CapitalBeijing
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Starnatx do?
- Starna Therapeutics develops RNA-based therapeutic drugs focused on hepatic and extrahepatic targeted delivery technology. The company has built a proprietary platform of cationic lipids and lipid nanoparticles (LNPs) to achieve organ-specific delivery and is advancing clinical-stage mRNA vaccine and mRNA therapeutic candidates.
- Who are Starnatx's investors?
- Starnatx's investors include Source Code Capital.
- Where is Starnatx headquartered?
- Starnatx is headquartered in Suzhou, CN.
